PPARγ Activation Modulates Macrophage Polarization in IBD Mo
2026-07-15
The reference study demonstrates that PPARγ activation shifts macrophage polarization from the proinflammatory M1 phenotype toward the anti-inflammatory M2 state in both cellular and mouse models of inflammatory bowel disease (IBD). These findings reveal a STAT-1/STAT-6-dependent mechanism, providing new insight into immunometabolic regulation and potential therapeutic targets for IBD.
Trypsin (BA5744): Advanced Serine Protease for NIR-II Imagin
2026-07-14
Discover how Trypsin, a vital serine protease, is revolutionizing cell biology and NIR-II imaging assays. This article delves into cutting-edge applications, unique mechanistic insights, and practical protocols beyond standard protein digestion.
Metal-Free Carbon Nanozymes Enable Sensitive ALP Detection
2026-07-14
The reference study introduces a metal-free carbon dot nanozyme assay for highly sensitive and specific detection of alkaline phosphatase (ALP) activity. This innovation overcomes the selectivity and cytotoxicity issues of traditional metal-based nanozymes, providing a practical tool for enzyme activity analysis in complex biological samples.
Necrostatin-1: RIP1 Kinase Inhibitor for Necroptosis Assays
2026-07-13
Necrostatin-1, a selective RIP1 kinase inhibitor, is revolutionizing necroptosis assays and inflammatory disease models by enabling precise control over cell death pathways. This guide translates the latest bench research and protocol optimizations into actionable workflows for acute kidney injury, liver inflammation, and cancer studies.
Decoding Neutrophil Isolation for Next-Gen Cancer Immunother
2026-07-13
This article dissects the mechanistic and strategic imperatives for high-purity mouse neutrophil isolation in translational immunotherapy. Anchoring on recent breakthroughs in biomimetic mRNA nanovaccine targeting of tumor-associated neutrophils, we connect rigorous protocol guidance with competitive landscape analysis. We highlight the APExBIO Mouse Neutrophil Cell Isolation Kit (Negative Selection) as a transformative platform, and advance the translational discussion beyond standard product presentations.
Angiotensin II as an Inflammatory Modulator: Novel Insights
2026-07-12
Explore the multifaceted role of Angiotensin II in inflammatory signaling and vascular remodeling. This in-depth analysis reveals new assay strategies and mechanistic insights, distinguishing it from protocol-focused guides.
Rotigotine: Dopamine D2/D3 Agonist for Advanced PD Research
2026-07-10
Rotigotine stands out as a high-affinity dopamine D2/D3 receptor agonist with proven neuroprotective and antioxidant properties, powering experimental models in Parkinson’s disease and beyond. This article delivers actionable protocols, troubleshooting guidance, and workflow enhancements to maximize the translational impact of Rotigotine in cell-based and in vivo research.
Itraconazole: Triazole Antifungal Agent for Advanced Biofilm
2026-07-09
Itraconazole, a potent triazole antifungal agent, enables rigorous studies of Candida biofilm drug resistance and CYP3A-mediated metabolism. This guide details how to harness its unique mechanisms, optimize experimental workflows, and troubleshoot technical challenges for reproducible, translational research outcomes.
Suhuang Capsule Inhibits ER Stress and NLRP3 Inflammasome in
2026-07-09
This study reveals that Suhuang antitussive capsule ameliorates pulmonary dysfunction in cough variant asthma by suppressing endoplasmic reticulum (ER) stress and inhibiting NLRP3 inflammasome activation. The findings provide mechanistic insight into how targeting RIP1-RIP3 signaling impacts inflammation-driven respiratory pathology.
Dimethyloxalylglycine (DMOG): Technical Use & Workflow Guida
2026-07-08
Dimethyloxalylglycine (DMOG) is a cell-permeable, competitive PHD inhibitor designed to stabilize hypoxia-inducible factors in laboratory models. It is intended for research applications involving oxygen sensing and hypoxia signaling pathways, but should not be used in diagnostic or clinical workflows.
BicD and MAP7 Synergize to Activate Drosophila Kinesin-1
2026-07-08
This study reveals how Drosophila BicD and MAP7 proteins collaboratively relieve kinesin-1 auto-inhibition and enhance processive motility on microtubules. By dissecting their complementary mechanisms, the authors provide new molecular insights into motor protein regulation relevant for cell biology and protein trafficking research.
Pyroptosis-Related Genes and GSDMC as a Target in Pancreatic
2026-07-07
Yan et al. developed a robust prognostic model for pancreatic adenocarcinoma (PAAD) based on pyroptosis-related gene expression, identifying GSDMC as a novel therapeutic target. Their integrative analysis highlights the utility of gene signatures for risk stratification and drug sensitivity prediction, offering fresh avenues for individualized PAAD treatment.
CD44-Driven Metabolic Rewiring in IDH-Mutant AML: A Targetab
2026-07-07
This article examines how the reference study revealed CD44-mediated metabolic rewiring as a critical dependency in IDH-mutant acute myeloid leukemia. The findings highlight novel mechanistic links between oncometabolite production and cell adhesion, with implications for combinatorial therapeutic strategies and research into overcoming resistance to current IDH inhibitors.
(R)-MG132: Precision Negative Control for Proteasome Assay V
2026-07-06
(R)-MG132 is a stereoisomer of MG-132 with minimal proteasome inhibition, offering unmatched specificity as a control in ubiquitin-proteasome system research. This article explores its unique biochemical properties, advanced applications, and critical role in mechanistic studies that go beyond prior content.
Nicotine Signaling Accelerates CKD Progression in Smokers
2026-07-06
This paper provides a comprehensive review of how nicotine, via activation of non-neuronal nicotinic acetylcholine receptors, accelerates chronic kidney disease (CKD) progression in smokers. The analysis integrates clinical and experimental evidence, highlighting pathways involving oxidative stress and fibrosis, and suggests new avenues for targeting nicotine-driven kidney injury.
461 records 12/31 page Previous Next First page 上5页 1112131415 下5页 Last page